| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,489 |
9,471 |
$1.17M |
| 99215 |
Prolong outpt/office vis |
1,783 |
1,595 |
$294K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
144 |
129 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,026 |
847 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
76 |
76 |
$13K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
86 |
81 |
$6K |
| 90674 |
|
167 |
146 |
$4K |
| 3074F |
|
4,880 |
4,330 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
92 |
84 |
$4K |
| 99385 |
|
28 |
27 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
215 |
185 |
$4K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$3K |
| 3078F |
|
3,794 |
3,397 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
202 |
144 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,062 |
976 |
$2K |
| 3079F |
|
1,889 |
1,668 |
$1K |
| 3075F |
|
493 |
432 |
$687.41 |
| 90756 |
|
24 |
24 |
$524.40 |
| 87428 |
|
16 |
12 |
$458.24 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
261 |
201 |
$454.22 |
| 3077F |
|
308 |
264 |
$202.30 |
| 3080F |
|
249 |
206 |
$158.80 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
109 |
102 |
$0.30 |